accueil

Sofinnova Partners is a leading European venture capital firm specialized in Life Sciences. Based in Paris, London, and Milan, the firm brings together a team of over 45 professionals from all over Europe, the U.S., and Asia. 

The firm focuses on paradigm-shifting technologies alongside visionary entrepreneurs. Sofinnova Partners invests across the Life Sciences value chain as a lead or cornerstone investor, from very early-stage opportunities to later-stage and public companies. It has backed more than 500 companies throughout five decades, creating market leaders around the globe. Today, Sofinnova Partners has over €2 billion under management.

Sofinnova Partners invest in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations. The firm invests in Life Sciences (Biopharmaceuticals, Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. The firm's partners sit on the boards of its portfolio companies and play an active role in the formation phase alongside entrepreneurs. Sofinnova Partners invests throughout Europe with a portion of investments made in the rest of the world.

View More

GHENT, Belgium and RESEARCH TRIANGLE PARK, N.C., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Today, Biotalys NV, a transformative food and crop protection company, announces that it has submitted its first protein-based biocontrol, Evoca™, to the Environmental Protectio...

Paris, France & San Francisco, California, USA, January 13th, 2021 - Moon Surgical, formerly MastOR, is delighted to announce the addition of three seasoned medtech executives to the leadership team: Jeffery Alvarez as Chief Operating Officer, David Noonan as ...

Clichy, France, January 6th, 2021 – CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients.   The capital increase is subscribed by returning investor...

Collaboration Strengthens Peijia's Position for Competing in a Largely Untapped Market and Supports Global Expansion of HighLife's Technology   SUZHOU, China and PARIS, Dec. 20, 2020/PRNewswire/ -- Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, a ...

The U.S. agreement expands Siemens Healthineers respiratory care portfolio to include critical care ventilators   NEW YORK, Dec. 15, 2020 /PRNewswire/ -- CorVent Medical, a Coridea portfolio company focused on developing smart, reusable, lifesaving ventilators...

Henrijette Richter

Henrijette Richter

Managing Partner

MEET OUR TEAM